Clal Biotechnology Industries Ltd.
About Clal Biotechnology Industries
Powered with strategic vision and financial vigor, Clal Biotechnology Industries (CBI) Ltd is one of the largest biotechnology investment entities in Israel. CBI targets promising companies with innovative bio-pharma technologies and transforms them into thriving, productive businesses.
Backed by Clal Industries and Investments, one of Israel's largest investment companies (owned by IDB group), and Teva Pharmaceutical Industries, the world's largest manufacturer of generic drugs, CBI successfully leverages its unique investment model of large-scale, long-term financial and managerial commitment to yield significant results and valued creation.
Clal Biotechnology Industries portfolio includes D-Pharm, Mediwound, Cure Tech, Andromeda, NST, Polyheal, Compugen, and BioCancell.
- Industry : Pharma
